International Guideline on Dose Prioritization and Acceptance Criteria in Radiation Therapy Planning for Nasopharyngeal Carcinoma
Anne W.M. Lee(Chinese University of Hong Kong), Joseph Wee(SingHealth), William M. Mendenhall(Florida College), Quynh‐Thu Le(Stanford University), Yoke Lim Soong(National Cancer Centre Singapore), June Corry(St Vincent's Hospital Melbourne), Enis Özyar(Acıbadem University), David I. Rosenthal(The University of Texas MD Anderson Cancer Center), Wai Tong Ng(Pamela Youde Nethersole Eastern Hospital), Brian O’Sullivan(University of Toronto), Cai Grau(Aarhus University Hospital), Nancy Y. Lee(Memorial Sloan Kettering Cancer Center), Chi‐Leung Chiang(University of Hong Kong - Shenzhen Hospital), Cheuk‐Wai Choi(University of Hong Kong), Kevin J. Harrington(Royal Marsden NHS Foundation Trust), Sue S. Yom(University of California, San Francisco), Sharon Shuxian Poh(Duke-NUS Medical School), Yong Chan Ahn(Samsung Medical Center), Chaosu Hu(Ministry of Agriculture and Rural Affairs), Hussain AlHussain(King Fahd Medical City), Vincent Grégoire(Centre Léon Bérard), Yungan Tao(Université Paris-Saclay), Tai Xiang Lu(Sun Yat-sen University), Lester J. Peters(Peter MacCallum Cancer Centre), Dora L.�W. Kwong(University of Hong Kong), Johannes A. Langendijk(University of Groningen), Jin Lin(National Yang Ming Chiao Tung University), Giuseppe Sanguineti(National Cancer Institute)
International Journal of Radiation Oncology*Biology*Physics
July 2, 2019
Cited by 183
Related Papers
Nivolumab for Recurrent Squamous-Cell Carcinoma of the Head and Neck
|New England Journal of Medicine|2016|5.1k
Tumor mutational load predicts survival after immunotherapy across multiple cancer types
|Nature Genetics|2019|4.4k
Postoperative Concurrent Radiotherapy and Chemotherapy for High-Risk Squamous-Cell Carcinoma of the Head and Neck
|New England Journal of Medicine|2004|3.2k